Clinical Trial Update: A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the combination of dinaciclib and rituximab in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Dinaciclib (dinaciclib)
• Rituximab (rituximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: COMPLETED